Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Change in Cash (2016 - 2026)

Corvus Pharmaceuticals' Change in Cash history spans 12 years, with the latest figure at $35.5 million for Q1 2026.

  • Quarterly Change in Cash rose 1049.64% to $35.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $35.1 million through Mar 2026, up 1528.69% year-over-year, with the annual reading at -$4.2 million for FY2025, 7.32% down from the prior year.
  • Change in Cash came in at $35.5 million for Q1 2026, up from $1.7 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $35.5 million in Q1 2026 to a low of -$32.0 million in Q1 2022.
  • The 5-year median for Change in Cash is -$3.5 million (2023), against an average of -$1.4 million.
  • Year-over-year, Change in Cash tumbled 211.69% in 2022 and then surged 1049.64% in 2026.
  • Corvus Pharmaceuticals' Change in Cash stood at -$11.4 million in 2022, then soared by 34.51% to -$7.5 million in 2023, then soared by 154.24% to $4.1 million in 2024, then plummeted by 57.91% to $1.7 million in 2025, then skyrocketed by 1978.76% to $35.5 million in 2026.
  • Per Business Quant, the three most recent readings for CRVS's Change in Cash are $35.5 million (Q1 2026), $1.7 million (Q4 2025), and -$11.8 million (Q3 2025).